A new data analysis suggests that two rising public health threats — climate change and antibiotic resistance — are related. The study, spanning 2000 to 2016, doesn’t establish cause and effect. But its findings, in the journal Eurosurveillance, suggest that rising global temperatures could be helping to fuel increases in antibiotic-resistant bacteria. Key takeaway Countries ... Read More about Rising global temperatures tied to rising antibiotic resistance
Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard for people to sustain. Moreover, the bacteria often develop drug resistance, and many people harbor multi-drug-resistant strains. In 2018 alone, nearly 1.5 million people died from tuberculosis worldwide. Now, a study in iScience suggests a new approach that ... Read More about Boosting host immune defenses to treat tuberculosis
Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly, highly contagious infection. In meticulous experiments in human cells, described today in iScience, the drug significantly amplified immune responses to the virus and inhibited ... Read More about Existing anti-parasitic drug could offer a treatment for Ebola
Every year, nearly 400,000 children worldwide develop hydrocephalus, in which excess fluid accumulates in the brain. Many of these children have shunts placed to allow this fluid to drain. Antibiotic-impregnated shunts are widely championed as the best choice, but a recent study calls their necessity into question. The study, published in the Journal of Neurosurgery ... Read More about Do antibiotic-impregnated shunts reduce infection in hydrocephalus?
Clostridium difficile, also called “C. diff,” tops the CDC’s list of urgent drug-resistant threats. Marked by severe diarrhea and intestinal inflammation, C. diff has become a leading cause of death from gastrointestinal illness, causing half a million infections a year in the U.S. alone. C. diff flourishes best in hospitals and long-term care facilities where people are on ... Read More about Entry door for deadly C. difficile toxin suggests new mode of protection